Colangiocarcinoma (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Colangiocarcinoma" in Italian language version.

refsWebsite

Global rank Italian rank

77nih.gov

4^th place

9^th place

56doi.org

2^nd place

7^th place

35archive.org

6^th place

8^th place

29oadoi.org

799^th place

22^nd place

7web.archive.org

1^st place

3cancer.gov

1,684^th place

2,574^th place

1startoncology.net

low place

1usc.edu

1,077^th place

1,956^th place

1nccn.org

low place

1springerlink.com

2,569^th place

2,344^th place

1fondazionefegato.it

low place

archive.org

Weber S, DeMatteo R, Fong Y, Blumgart L, Jarnagin W, Staging Laparoscopy in Patients With Extrahepatic Biliary Carcinoma: Analysis of 100 Patients, in Ann Surg, vol. 235, n. 3, 2002, pp. 392–9, DOI:10.1097/00000658-200203000-00011, PMC 1422445, PMID 11882761.
Vauthey J, Blumgart L, Recent advances in the management of cholangiocarcinomas, in Semin. Liver Dis., vol. 14, n. 2, 1994, pp. 109–14, DOI:10.1055/s-2007-1007302, PMID 8047893.
Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J, Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors, in Ann Surg, vol. 224, n. 4, 1996, pp. 463–73; discussion 473–5, DOI:10.1097/00000658-199610000-00005, PMC 1235406, PMID 8857851.
Rosen C, Nagorney D, Wiesner R, Coffey R, LaRusso N, Cholangiocarcinoma complicating primary sclerosing cholangitis, in Ann Surg, vol. 213, n. 1, 1991, pp. 21–5, DOI:10.1097/00000658-199101000-00004, PMC 1358305, PMID 1845927.
Watanapa P, Cholangiocarcinoma in patients with opisthorchiasis, in Br J Surg, vol. 83, n. 8, 1996, pp. 1062–64, DOI:10.1002/bjs.1800830809, PMID 8869303.
Watanapa P, Watanapa W, Liver fluke-associated cholangiocarcinoma, in Br J Surg, vol. 89, n. 8, 2002, pp. 962–70, DOI:10.1046/j.1365-2168.2002.02143.x, PMID 12153620.
Shin H, Lee C, Park H, Seol S, Chung J, Choi H, Ahn Y, Shigemastu T, Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea, in Int J Epidemiol, vol. 25, n. 5, 1996, pp. 933–40, DOI:10.1093/ije/25.5.933, PMID 8921477.
Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T, Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma, in Cancer Sci, vol. 95, n. 7, 2004, pp. 592–5, DOI:10.1111/j.1349-7006.2004.tb02492.x, PMID 15245596.
Shaib Y, El-Serag H, Davila J, Morgan R, McGlynn K, Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study, in Gastroenterology, vol. 128, n. 3, 2005, pp. 620–6, DOI:10.1053/j.gastro.2004.12.048, PMID 15765398.
Sorensen H, Friis S, Olsen J, Thulstrup A, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J, Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark, in Hepatology, vol. 28, n. 4, 1998, pp. 921–5, DOI:10.1002/hep.510280404, PMID 9755226.
Lipsett P, Pitt H, Colombani P, Boitnott J, Cameron J, Choledochal cyst disease. A changing pattern of presentation, in Ann Surg, vol. 220, n. 5, 1994, pp. 644–52, DOI:10.1097/00000658-199411000-00007, PMC 1234452, PMID 7979612.
Lee C, Wu C, Chen G, What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?, in J Gastroenterol Hepatol, vol. 17, n. 9, 2002, pp. 1015–20, DOI:10.1046/j.1440-1746.2002.02779.x, PMID 12167124.
Su C, Shyr Y, Lui W, P'Eng F, Hepatolithiasis associated with cholangiocarcinoma, in Br J Surg, vol. 84, n. 7, 1997, pp. 969–73, DOI:10.1002/bjs.1800840717, PMID 9240138.
KLATSKIN G, Adenocarcinoma Of The Hepatic Duct At Its Bifurcation Within The Porta Hepatis. An Unusual Tumor With Distinctive Clinical And Pathological Features, in Am J Med, vol. 38, n. 2, 1965, pp. 241–56, DOI:10.1016/0002-9343(65)90178-6, PMID 14256720.
Sell S, Dunsford H, Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma, in Am J Pathol, vol. 134, n. 6, 1989, pp. 1347–63, PMC 1879951, PMID 2474256.
Gores G, Cholangiocarcinoma: current concepts and insights, in Hepatology, vol. 37, n. 5, 2003, pp. 961–9, DOI:10.1053/jhep.2003.50200, PMID 12717374.
Tra gli studi che hanno messo in evidenza il ruolo del dosaggio dei markers tumorali per il colangiocarcinoma (come l'antigene carcinoembrionario e il CA19-9) in pazienti affetti e non da colangite sclerosante primitiva sono compresi:
- Nehls O, Gregor M, Klump B, Serum and bile markers for cholangiocarcinoma, in Semin Liver Dis
- Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G, Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures, in Gut, vol. 46, n. 1, 2000, pp. 103–6, DOI:10.1136/gut.46.1.103, PMC 1727781, PMID 10601064.
- Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E, Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography, in World J Surg, vol. 27, n. 3, 2003, pp. 278–83, DOI:10.1007/s00268-002-6701-1, PMID 12607051.
- Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M, Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings, in Am J Gastroenterol, vol. 95, n. 2, 2000, pp. 432–40, DOI:10.1111/j.1572-0241.2000.01763.x, PMID 10685746.
- Callery M, Strasberg S, Doherty G, Soper N, Norton J, Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy, in J Am Coll Surg, vol. 185, n. 1, 1997, pp. 33–9, PMID 9208958.
- Sobin LH, Gospodarowicz MK, Wittekind Ch., TNM Classification of Malignant Tumors, Oxford, Wiley-Blackwell, 2009, ISBN 978-1-4443-3241-4.
- Su C, Tsay S, Wu C, Shyr Y, King K, Lee C, Lui W, Liu T, P'eng F, Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma, in Ann Surg, vol. 223, n. 4, 1996, pp. 384–94, DOI:10.1097/00000658-199604000-00007, PMC 1235134, PMID 8633917.
- Pitt H, Nakeeb A, Abrams R, Coleman J, Piantadosi S, Yeo C, Lillemore K, Cameron J, Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival, in Ann Surg, vol. 221, n. 6, 1995, pp. 788–97; discussion 797–8, DOI:10.1097/00000658-199506000-00017, PMC 1234714, PMID 7794082.
- Glimelius B, Hoffman K, Sjödén P, Jacobsson G, Sellström H, Enander L, Linné T, Svensson C, Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer, in Ann Oncol, vol. 7, n. 6, 1996, pp. 593–600, PMID 8879373.
- Ortner M, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J, Lochs H, Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study, in Gastroenterology, vol. 125, n. 5, 2003, pp. 1355–63, DOI:10.1016/j.gastro.2003.07.015, PMID 14598251.
- Zoepf T, Jakobs R, Arnold J, Apel D, Riemann J, Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy, in Am J Gastroenterol, vol. 100, n. 11, 2005, pp. 2426–30, DOI:10.1111/j.1572-0241.2005.00318.x, PMID 16279895.
- Farley D, Weaver A, Nagorney D, "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention, in Mayo Clin Proc, vol. 70, n. 5, 1995, pp. 425–9, DOI:10.4065/70.5.425, PMID 7537346.
- Grove MK, Hermann RE, Vogt DP, Broughan TA, Role of radiation after operative palliation in cancer of the proximal bile ducts, in Am J Surg, vol. 161, n. 4, 1991, pp. 454–458, DOI:10.1016/0002-9610(91)91111-U, PMID 1709795.
- Studi dei risultati chirurgici del colangiocarcinoma distale includono:
  - Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J, Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors, in Ann Surg
  - Tra gli studi dei risultati operatori di colangiocarcinomi intraepatici sono annoverati:
    - Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J, Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors, in Ann Surg
    - Tra le stime sulla sopravvivenza post-chirurgica di pazienti operati per colangiocarcinoma periilare sono compresi i seguenti studi:
      - Burke E, Jarnagin W, Hochwald S, Pisters P, Fong Y, Blumgart L, Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system, in Ann Surg
      - Kaya M, de Groen P, Angulo P, Nagorney D, Gunderson L, Gores G, Haddock M, Lindor K, Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience, in Am J Gastroenterol, vol. 96, n. 4, 2001, pp. 1164–9, DOI:10.1111/j.1572-0241.2001.03696.x, PMID 11316165.
      - Nakeeb A, Tran K, Black M, Erickson B, Ritch P, Quebbeman E, Wilson S, Demeure M, Rilling W, Dua K, Pitt H, Improved survival in resected biliary malignancies, in Surgery, vol. 132, n. 4, 2002, pp. 555–63; discission 563–4, DOI:10.1067/msy.2002.127555, PMID 12407338.
      - Vauthey J, Blumgart L, Recent advances in the management of cholangiocarcinomas, in Semin Liver Dis, vol. 14, n. 2, 1994, pp. 109–14, DOI:10.1055/s-2007-1007302, PMID 8047893.

cancer.gov

(EN) Stadiazione: Domande & Risposte" a cura dell'Istituto Nazionale dei Tumori Americano, su cancer.gov. URL consultato il 2 gennaio 2012 (archiviato il 19 marzo 2015).
Cancer Statistics Home Page - National Cancer Institute, su cancer.gov. URL consultato il 15 ottobre 2011 (archiviato il 29 aprile 2015).

seer.cancer.gov

Copia archiviata (PDF), su seer.cancer.gov. URL consultato il 15 ottobre 2011 (archiviato il 15 ottobre 2011).

doi.org

dx.doi.org

Landis S, Murray T, Bolden S, Wingo P, Cancer statistics, 1998, in CA Cancer J Clin, vol. 48, n. 1, 1998, pp. 6–29, DOI:10.3322/canjclin.48.1.6, PMID 9449931.
Patel T, Worldwide trends in mortality from biliary tract malignancies, in BMC Cancer, vol. 2, 2002, p. 10, DOI:10.1186/1471-2407-2-10, PMC 113759, PMID 11991810.
Weber S, DeMatteo R, Fong Y, Blumgart L, Jarnagin W, Staging Laparoscopy in Patients With Extrahepatic Biliary Carcinoma: Analysis of 100 Patients, in Ann Surg, vol. 235, n. 3, 2002, pp. 392–9, DOI:10.1097/00000658-200203000-00011, PMC 1422445, PMID 11882761.
Vauthey J, Blumgart L, Recent advances in the management of cholangiocarcinomas, in Semin. Liver Dis., vol. 14, n. 2, 1994, pp. 109–14, DOI:10.1055/s-2007-1007302, PMID 8047893.
Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J, Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors, in Ann Surg, vol. 224, n. 4, 1996, pp. 463–73; discussion 473–5, DOI:10.1097/00000658-199610000-00005, PMC 1235406, PMID 8857851.
Rosen C, Nagorney D, Wiesner R, Coffey R, LaRusso N, Cholangiocarcinoma complicating primary sclerosing cholangitis, in Ann Surg, vol. 213, n. 1, 1991, pp. 21–5, DOI:10.1097/00000658-199101000-00004, PMC 1358305, PMID 1845927.
Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S, Thorotrast-induced cholangiocarcinoma: case report, in Abdom Imaging, vol. 28, n. 1, 2003, pp. 72–4, DOI:10.1007/s00261-001-0148-y, PMID 12483389.
Zhu A, Lauwers G, Tanabe K, Cholangiocarcinoma in association with Thorotrast exposure, in J Hepatobiliary Pancreat Surg, vol. 11, n. 6, 2004, pp. 430–3, DOI:10.1007/s00534-004-0924-5, PMID 15619021.
Watanapa P, Cholangiocarcinoma in patients with opisthorchiasis, in Br J Surg, vol. 83, n. 8, 1996, pp. 1062–64, DOI:10.1002/bjs.1800830809, PMID 8869303.
Watanapa P, Watanapa W, Liver fluke-associated cholangiocarcinoma, in Br J Surg, vol. 89, n. 8, 2002, pp. 962–70, DOI:10.1046/j.1365-2168.2002.02143.x, PMID 12153620.
Shin H, Lee C, Park H, Seol S, Chung J, Choi H, Ahn Y, Shigemastu T, Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea, in Int J Epidemiol, vol. 25, n. 5, 1996, pp. 933–40, DOI:10.1093/ije/25.5.933, PMID 8921477.
Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H, <2471::AID-CNCR7>3.0.CO;2-T Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, in Cancer, vol. 88, n. 11, 2000, pp. 2471–7, DOI:10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T, PMID 10861422.
Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T, Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma, in Cancer Sci, vol. 95, n. 7, 2004, pp. 592–5, DOI:10.1111/j.1349-7006.2004.tb02492.x, PMID 15245596.
Shaib Y, El-Serag H, Davila J, Morgan R, McGlynn K, Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study, in Gastroenterology, vol. 128, n. 3, 2005, pp. 620–6, DOI:10.1053/j.gastro.2004.12.048, PMID 15765398.
Sorensen H, Friis S, Olsen J, Thulstrup A, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J, Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark, in Hepatology, vol. 28, n. 4, 1998, pp. 921–5, DOI:10.1002/hep.510280404, PMID 9755226.
Lipsett P, Pitt H, Colombani P, Boitnott J, Cameron J, Choledochal cyst disease. A changing pattern of presentation, in Ann Surg, vol. 220, n. 5, 1994, pp. 644–52, DOI:10.1097/00000658-199411000-00007, PMC 1234452, PMID 7979612.
Dayton M, Longmire W, Tompkins R, Caroli's Disease: a premalignant condition?, in Am J Surg, vol. 145, n. 1, 1983, pp. 41–8, DOI:10.1016/0002-9610(83)90164-2, PMID 6295196.
Mecklin J, Järvinen H, Virolainen M, The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma, in Cancer, vol. 69, n. 5, 1992, pp. 1112–4, DOI:10.1002/cncr.2820690508, PMID 1310886.
Lee S, Kim M, Lee S, Jang S, Song M, Kim K, Kim H, Seo D, Song D, Yu E, Lee S, Min Y, Clinicopathologic review of 58 patients with biliary papillomatosis, in Cancer, vol. 100, n. 4, 2004, pp. 783–93, DOI:10.1002/cncr.20031, PMID 14770435.
Lee C, Wu C, Chen G, What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?, in J Gastroenterol Hepatol, vol. 17, n. 9, 2002, pp. 1015–20, DOI:10.1046/j.1440-1746.2002.02779.x, PMID 12167124.
Su C, Shyr Y, Lui W, P'Eng F, Hepatolithiasis associated with cholangiocarcinoma, in Br J Surg, vol. 84, n. 7, 1997, pp. 969–73, DOI:10.1002/bjs.1800840717, PMID 9240138.
Donato F, Gelatti U, Tagger A, Favret M, Ribero M, Callea F, Martelli C, Savio A, Trevisi P, Nardi G, Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy, in Cancer Causes Control, vol. 12, n. 10, 2001, pp. 959–64, DOI:10.1023/A:1013747228572, PMID 11808716.
KLATSKIN G, Adenocarcinoma Of The Hepatic Duct At Its Bifurcation Within The Porta Hepatis. An Unusual Tumor With Distinctive Clinical And Pathological Features, in Am J Med, vol. 38, n. 2, 1965, pp. 241–56, DOI:10.1016/0002-9343(65)90178-6, PMID 14256720.
Roskams T, Liver stem cells and their implication in hepatocellular and cholangiocarcinoma, in Oncogene, vol. 25, n. 27, 2006, pp. 3818–22, DOI:10.1038/sj.onc.1209558, PMID 16799623.
Sirica A, Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy, in Hepatology, vol. 41, n. 1, 2005, pp. 5–15, DOI:10.1002/hep.20537, PMID 15690474.
Gores G, Cholangiocarcinoma: current concepts and insights, in Hepatology, vol. 37, n. 5, 2003, pp. 961–9, DOI:10.1053/jhep.2003.50200, PMID 12717374.
de Groen P, Gores G, LaRusso N, Gunderson L, Nagorney D, Biliary tract cancers, in N Engl J Med, vol. 341, n. 18, 1999, pp. 1368–78, DOI:10.1056/NEJM199910283411807, PMID 10536130.
Henson D, Albores-Saavedra J, Corle D, <1498::AID-CNCR2820700609>3.0.CO;2-C Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates, in Cancer, vol. 70, n. 6, 1992, pp. 1498–501, DOI:10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C, PMID 1516001.
Saini S, Imaging of the hepatobiliary tract, in N Engl J Med, vol. 336, n. 26, 1997, pp. 1889–94, DOI:10.1056/NEJM199706263362607, PMID 9197218.
Valls C, Gumà A, Puig I, Sanchez A, Andía E, Serrano T, Figueras J, Intrahepatic peripheral cholangiocarcinoma: CT evaluation, in Abdom Imaging, vol. 25, n. 5, 2000, pp. 490–6, DOI:10.1007/s002610000079, PMID 10931983.
Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y, Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI, in J Comput Assist Tomogr, vol. 23, n. 5, 1999, pp. 670–7, DOI:10.1097/00004728-199909000-00004, PMID 10524843.
Sugiyama M, Hagi H, Atomi Y, Saito M, Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography, in Abdom Imaging, vol. 22, n. 4, 1997, pp. 434–8, DOI:10.1007/s002619900227, PMID 9157867.
Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G, Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures, in Gut, vol. 46, n. 1, 2000, pp. 103–6, DOI:10.1136/gut.46.1.103, PMC 1727781, PMID 10601064.
Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E, Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography, in World J Surg, vol. 27, n. 3, 2003, pp. 278–83, DOI:10.1007/s00268-002-6701-1, PMID 12607051.
Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M, Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings, in Am J Gastroenterol, vol. 95, n. 2, 2000, pp. 432–40, DOI:10.1111/j.1572-0241.2000.01763.x, PMID 10685746.
Szklaruk J, Tamm E, Charnsangavej C, Preoperative imaging of biliary tract cancers, in Surg Oncol Clin N Am, vol. 11, n. 4, 2002, pp. 865–76, DOI:10.1016/S1055-3207(02)00032-7, PMID 12607576.
(DE) Länger F, von Wasielewski R, Kreipe HH, [The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas], in Pathologe, vol. 27, n. 4, 2006, pp. 244–50, DOI:10.1007/s00292-006-0836-z, PMID 16758167.
Su C, Tsay S, Wu C, Shyr Y, King K, Lee C, Lui W, Liu T, P'eng F, Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma, in Ann Surg, vol. 223, n. 4, 1996, pp. 384–94, DOI:10.1097/00000658-199604000-00007, PMC 1235134, PMID 8633917.
Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K, Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma, in Int J Radiat Oncol Biol Phys, vol. 46, n. 3, 2000, pp. 581–7, DOI:10.1016/S0360-3016(99)00472-1, PMID 10701737.
Alden M, Mohiuddin M, The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer, in Int J Radiat Oncol Biol Phys, vol. 28, n. 4, 1994, pp. 945–51, DOI:10.1016/0360-3016(94)90115-5, PMID 8138448.
Pitt H, Nakeeb A, Abrams R, Coleman J, Piantadosi S, Yeo C, Lillemore K, Cameron J, Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival, in Ann Surg, vol. 221, n. 6, 1995, pp. 788–97; discussion 797–8, DOI:10.1097/00000658-199506000-00017, PMC 1234714, PMID 7794082.
Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma, in Cancer, vol. 95, n. 8, 2002, pp. 1685–95, DOI:10.1002/cncr.10831, PMID 12365016.
Choi C, Choi I, Seo J, Kim B, Kim J, Kim C, Um S, Kim J, Kim Y, Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas, in Am J Clin Oncol, vol. 23, n. 4, 2000, pp. 425–8, DOI:10.1097/00000421-200008000-00023, PMID 10955877.
Park J, Oh S, Kim S, Kwon H, Kim J, Jin-Kim H, Kim Y, Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study, in Jpn J Clin Oncol, vol. 35, n. 2, 2005, pp. 68–73, DOI:10.1093/jjco/hyi021, PMID 15709089.
Giuliani F, Gebbia V, Maiello E, Borsellino N, Bajardi E, Colucci G, Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM), in Ann Oncol, 17 Suppl 7, 2006, pp. vii73–vii77, DOI:10.1093/annonc/mdl956, PMID 16760299.
Knox J, Hedley D, Oza A, Feld R, Siu L, Chen E, Nematollahi M, Pond G, Zhang J, Moore M, Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial, in J Clin Oncol, vol. 23, n. 10, 2005, pp. 2332–8, DOI:10.1200/JCO.2005.51.008, PMID 15800324.
Philip P, Mahoney M, Allmer C, Thomas J, Pitot H, Kim G, Donehower R, Fitch T, Picus J, Erlichman C, Phase II study of erlotinib in patients with advanced biliary cancer, in J Clin Oncol, vol. 24, n. 19, 2006, pp. 3069–74, DOI:10.1200/JCO.2005.05.3579, PMID 16809731.
Ortner M, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J, Lochs H, Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study, in Gastroenterology, vol. 125, n. 5, 2003, pp. 1355–63, DOI:10.1016/j.gastro.2003.07.015, PMID 14598251.
Zoepf T, Jakobs R, Arnold J, Apel D, Riemann J, Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy, in Am J Gastroenterol, vol. 100, n. 11, 2005, pp. 2426–30, DOI:10.1111/j.1572-0241.2005.00318.x, PMID 16279895.
Yamamoto M, Takasaki K, Yoshikawa T, Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma, in Japanese Journal of Clinical Oncology, vol. 29, n. 3, 1999, pp. 147–150, DOI:10.1093/jjco/29.3.147, PMID 10225697.
Farley D, Weaver A, Nagorney D, "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention, in Mayo Clin Proc, vol. 70, n. 5, 1995, pp. 425–9, DOI:10.4065/70.5.425, PMID 7537346.
Grove MK, Hermann RE, Vogt DP, Broughan TA, Role of radiation after operative palliation in cancer of the proximal bile ducts, in Am J Surg, vol. 161, n. 4, 1991, pp. 454–458, DOI:10.1016/0002-9610(91)91111-U, PMID 1709795.
Kaya M, de Groen P, Angulo P, Nagorney D, Gunderson L, Gores G, Haddock M, Lindor K, Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience, in Am J Gastroenterol, vol. 96, n. 4, 2001, pp. 1164–9, DOI:10.1111/j.1572-0241.2001.03696.x, PMID 11316165.
Nakeeb A, Tran K, Black M, Erickson B, Ritch P, Quebbeman E, Wilson S, Demeure M, Rilling W, Dua K, Pitt H, Improved survival in resected biliary malignancies, in Surgery, vol. 132, n. 4, 2002, pp. 555–63; discission 563–4, DOI:10.1067/msy.2002.127555, PMID 12407338.
Khan S, Taylor-Robinson S, Toledano M, Beck A, Elliott P, Thomas H, Changing international trends in mortality rates for liver, biliary and pancreatic tumours, in J Hepatol, vol. 37, n. 6, 2002, pp. 806–13, DOI:10.1016/S0168-8278(02)00297-0, PMID 12445422.
Vauthey J, Blumgart L, Recent advances in the management of cholangiocarcinomas, in Semin Liver Dis, vol. 14, n. 2, 1994, pp. 109–14, DOI:10.1055/s-2007-1007302, PMID 8047893.

fondazionefegato.it

Colangiocarcinoma, su fondazionefegato.it, Fondazione Italiana per la Ricerca in Epatologia. URL consultato il 2 gennaio 2011 (archiviato il 17 settembre 2011).

nccn.org

(EN) National Comprehensive Cancer Network (NCCN) guidelines on evaluation and treatment of hepatobiliary malignancies (PDF), su nccn.org. URL consultato il 13 marzo 2007 (archiviato il 26 marzo 2009).

nih.gov

ncbi.nlm.nih.gov

Landis S, Murray T, Bolden S, Wingo P, Cancer statistics, 1998, in CA Cancer J Clin, vol. 48, n. 1, 1998, pp. 6–29, DOI:10.3322/canjclin.48.1.6, PMID 9449931.
Patel T, Worldwide trends in mortality from biliary tract malignancies, in BMC Cancer, vol. 2, 2002, p. 10, DOI:10.1186/1471-2407-2-10, PMC 113759, PMID 11991810.
Gotthardt D, Chahoud F, Sauer P., Primary sclerosing cholangitis: diagnostic and therapeutic problems, in Endoscopy Live Berlin 2011 - Intestinal Disease Meeting, Vol. 29, Suppl 1, 2011, PMID 22104752.
Weber S, DeMatteo R, Fong Y, Blumgart L, Jarnagin W, Staging Laparoscopy in Patients With Extrahepatic Biliary Carcinoma: Analysis of 100 Patients, in Ann Surg, vol. 235, n. 3, 2002, pp. 392–9, DOI:10.1097/00000658-200203000-00011, PMC 1422445, PMID 11882761.
Vauthey J, Blumgart L, Recent advances in the management of cholangiocarcinomas, in Semin. Liver Dis., vol. 14, n. 2, 1994, pp. 109–14, DOI:10.1055/s-2007-1007302, PMID 8047893.
Poultsides GA, Zhu AX, Choti MA, Pawlik TM., Intrahepatic cholangiocarcinoma, in Surgical Clinics of North America, vol. 90, n. 4, pp. 817-837, PMID 20637950.
Nagorney D, Donohue J, Farnell M, Schleck C, Ilstrup D, Outcomes after curative resections of cholangiocarcinoma, in Arch Surg, vol. 128, n. 8, 1993, pp. 871–7; discussion 877–9, PMID 8393652.
Nakeeb A, Pitt H, Sohn T, Coleman J, Abrams R, Piantadosi S, Hruban R, Lillemoe K, Yeo C, Cameron J, Cholangiocarcinoma. A spectrum of intrahepatic, perihilar, and distal tumors, in Ann Surg, vol. 224, n. 4, 1996, pp. 463–73; discussion 473–5, DOI:10.1097/00000658-199610000-00005, PMC 1235406, PMID 8857851.
Chapman R, Risk factors for biliary tract carcinogenesis, in Ann Oncol, 10 Suppl 4, 1999, pp. 308–11, PMID 10436847.
Rosen C, Nagorney D, Wiesner R, Coffey R, LaRusso N, Cholangiocarcinoma complicating primary sclerosing cholangitis, in Ann Surg, vol. 213, n. 1, 1991, pp. 21–5, DOI:10.1097/00000658-199101000-00004, PMC 1358305, PMID 1845927.
Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S, Thorotrast-induced cholangiocarcinoma: case report, in Abdom Imaging, vol. 28, n. 1, 2003, pp. 72–4, DOI:10.1007/s00261-001-0148-y, PMID 12483389.
Zhu A, Lauwers G, Tanabe K, Cholangiocarcinoma in association with Thorotrast exposure, in J Hepatobiliary Pancreat Surg, vol. 11, n. 6, 2004, pp. 430–3, DOI:10.1007/s00534-004-0924-5, PMID 15619021.
Watanapa P, Cholangiocarcinoma in patients with opisthorchiasis, in Br J Surg, vol. 83, n. 8, 1996, pp. 1062–64, DOI:10.1002/bjs.1800830809, PMID 8869303.
Watanapa P, Watanapa W, Liver fluke-associated cholangiocarcinoma, in Br J Surg, vol. 89, n. 8, 2002, pp. 962–70, DOI:10.1046/j.1365-2168.2002.02143.x, PMID 12153620.
Shin H, Lee C, Park H, Seol S, Chung J, Choi H, Ahn Y, Shigemastu T, Hepatitis B and C virus, Clonorchis sinensis for the risk of liver cancer: a case-control study in Pusan, Korea, in Int J Epidemiol, vol. 25, n. 5, 1996, pp. 933–40, DOI:10.1093/ije/25.5.933, PMID 8921477.
Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H, <2471::AID-CNCR7>3.0.CO;2-T Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, in Cancer, vol. 88, n. 11, 2000, pp. 2471–7, DOI:10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T, PMID 10861422.
Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T, Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma, in Cancer Sci, vol. 95, n. 7, 2004, pp. 592–5, DOI:10.1111/j.1349-7006.2004.tb02492.x, PMID 15245596.
Lu H, Ye M, Thung S, Dash S, Gerber M, Detection of hepatitis C virus RNA sequences in cholangiocarcinomas in Chinese and American patients, in Chin Med J (Engl), vol. 113, n. 12, 2000, pp. 1138–41, PMID 11776153.
Shaib Y, El-Serag H, Davila J, Morgan R, McGlynn K, Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study, in Gastroenterology, vol. 128, n. 3, 2005, pp. 620–6, DOI:10.1053/j.gastro.2004.12.048, PMID 15765398.
Sorensen H, Friis S, Olsen J, Thulstrup A, Mellemkjaer L, Linet M, Trichopoulos D, Vilstrup H, Olsen J, Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark, in Hepatology, vol. 28, n. 4, 1998, pp. 921–5, DOI:10.1002/hep.510280404, PMID 9755226.
Lipsett P, Pitt H, Colombani P, Boitnott J, Cameron J, Choledochal cyst disease. A changing pattern of presentation, in Ann Surg, vol. 220, n. 5, 1994, pp. 644–52, DOI:10.1097/00000658-199411000-00007, PMC 1234452, PMID 7979612.
Dayton M, Longmire W, Tompkins R, Caroli's Disease: a premalignant condition?, in Am J Surg, vol. 145, n. 1, 1983, pp. 41–8, DOI:10.1016/0002-9610(83)90164-2, PMID 6295196.
Mecklin J, Järvinen H, Virolainen M, The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma, in Cancer, vol. 69, n. 5, 1992, pp. 1112–4, DOI:10.1002/cncr.2820690508, PMID 1310886.
Lee S, Kim M, Lee S, Jang S, Song M, Kim K, Kim H, Seo D, Song D, Yu E, Lee S, Min Y, Clinicopathologic review of 58 patients with biliary papillomatosis, in Cancer, vol. 100, n. 4, 2004, pp. 783–93, DOI:10.1002/cncr.20031, PMID 14770435.
Lee C, Wu C, Chen G, What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma?, in J Gastroenterol Hepatol, vol. 17, n. 9, 2002, pp. 1015–20, DOI:10.1046/j.1440-1746.2002.02779.x, PMID 12167124.
Su C, Shyr Y, Lui W, P'Eng F, Hepatolithiasis associated with cholangiocarcinoma, in Br J Surg, vol. 84, n. 7, 1997, pp. 969–73, DOI:10.1002/bjs.1800840717, PMID 9240138.
Donato F, Gelatti U, Tagger A, Favret M, Ribero M, Callea F, Martelli C, Savio A, Trevisi P, Nardi G, Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy, in Cancer Causes Control, vol. 12, n. 10, 2001, pp. 959–64, DOI:10.1023/A:1013747228572, PMID 11808716.
KLATSKIN G, Adenocarcinoma Of The Hepatic Duct At Its Bifurcation Within The Porta Hepatis. An Unusual Tumor With Distinctive Clinical And Pathological Features, in Am J Med, vol. 38, n. 2, 1965, pp. 241–56, DOI:10.1016/0002-9343(65)90178-6, PMID 14256720.
Roskams T, Liver stem cells and their implication in hepatocellular and cholangiocarcinoma, in Oncogene, vol. 25, n. 27, 2006, pp. 3818–22, DOI:10.1038/sj.onc.1209558, PMID 16799623.
Liu C, Wang J, Ou Q, Possible stem cell origin of human cholangiocarcinoma, in World J Gastroenterol, vol. 10, n. 22, 2004, pp. 3374–6, PMID 15484322.
Sell S, Dunsford H, Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocarcinoma, in Am J Pathol, vol. 134, n. 6, 1989, pp. 1347–63, PMC 1879951, PMID 2474256.
Sirica A, Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy, in Hepatology, vol. 41, n. 1, 2005, pp. 5–15, DOI:10.1002/hep.20537, PMID 15690474.
Holzinger F, Z'graggen K, Büchler M, Mechanisms of biliary carcinogenesis: a pathogenetic multi-stage cascade towards cholangiocarcinoma, in Ann Oncol, 10 Suppl 4, 1999, pp. 122–6, PMID 10436802.
Gores G, Cholangiocarcinoma: current concepts and insights, in Hepatology, vol. 37, n. 5, 2003, pp. 961–9, DOI:10.1053/jhep.2003.50200, PMID 12717374.
de Groen P, Gores G, LaRusso N, Gunderson L, Nagorney D, Biliary tract cancers, in N Engl J Med, vol. 341, n. 18, 1999, pp. 1368–78, DOI:10.1056/NEJM199910283411807, PMID 10536130.
Henson D, Albores-Saavedra J, Corle D, <1498::AID-CNCR2820700609>3.0.CO;2-C Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates, in Cancer, vol. 70, n. 6, 1992, pp. 1498–501, DOI:10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C, PMID 1516001.
Saini S, Imaging of the hepatobiliary tract, in N Engl J Med, vol. 336, n. 26, 1997, pp. 1889–94, DOI:10.1056/NEJM199706263362607, PMID 9197218.
Sharma M, Ahuja V, Aetiological spectrum of obstructive jaundice and diagnostic ability of ultrasonography: a clinician's perspective, in Trop Gastroenterol, vol. 20, n. 4, 1999, pp. 167–9, PMID 10769604.
Bloom C, Langer B, Wilson S, Role of US in the detection, characterization, and staging of cholangiocarcinoma, in Radiographics, vol. 19, n. 5, 1999, pp. 1199–218, PMID 10489176.
Valls C, Gumà A, Puig I, Sanchez A, Andía E, Serrano T, Figueras J, Intrahepatic peripheral cholangiocarcinoma: CT evaluation, in Abdom Imaging, vol. 25, n. 5, 2000, pp. 490–6, DOI:10.1007/s002610000079, PMID 10931983.
Tillich M, Mischinger H, Preisegger K, Rabl H, Szolar D, Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma, in AJR Am J Roentgenol, vol. 171, n. 3, 1998, pp. 651–8, PMID 9725291.
Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y, Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI, in J Comput Assist Tomogr, vol. 23, n. 5, 1999, pp. 670–7, DOI:10.1097/00004728-199909000-00004, PMID 10524843.
Sugiyama M, Hagi H, Atomi Y, Saito M, Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography, in Abdom Imaging, vol. 22, n. 4, 1997, pp. 434–8, DOI:10.1007/s002619900227, PMID 9157867.
Schwartz L, Coakley F, Sun Y, Blumgart L, Fong Y, Panicek D, Neoplastic pancreaticobiliary duct obstruction: evaluation with breath-hold MR cholangiopancreatography, in AJR Am J Roentgenol, vol. 170, n. 6, 1998, pp. 1491–5, PMID 9609160.
Zidi S, Prat F, Le Guen O, Rondeau Y, Pelletier G, Performance characteristics of magnetic resonance cholangiography in the staging of malignant hilar strictures, in Gut, vol. 46, n. 1, 2000, pp. 103–6, DOI:10.1136/gut.46.1.103, PMC 1727781, PMID 10601064.
Lee M, Park K, Shin Y, Yoon H, Sung K, Kim M, Lee S, Kang E, Preoperative evaluation of hilar cholangiocarcinoma with contrast-enhanced three-dimensional fast imaging with steady-state precession magnetic resonance angiography: comparison with intraarterial digital subtraction angiography, in World J Surg, vol. 27, n. 3, 2003, pp. 278–83, DOI:10.1007/s00268-002-6701-1, PMID 12607051.
Yeh T, Jan Y, Tseng J, Chiu C, Chen T, Hwang T, Chen M, Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings, in Am J Gastroenterol, vol. 95, n. 2, 2000, pp. 432–40, DOI:10.1111/j.1572-0241.2000.01763.x, PMID 10685746.
Freeman M, Sielaff T, A modern approach to malignant hilar biliary obstruction, in Rev Gastroenterol Disord, vol. 3, n. 4, 2003, pp. 187–201, PMID 14668691.
Szklaruk J, Tamm E, Charnsangavej C, Preoperative imaging of biliary tract cancers, in Surg Oncol Clin N Am, vol. 11, n. 4, 2002, pp. 865–76, DOI:10.1016/S1055-3207(02)00032-7, PMID 12607576.
Callery M, Strasberg S, Doherty G, Soper N, Norton J, Staging laparoscopy with laparoscopic ultrasonography: optimizing resectability in hepatobiliary and pancreatic malignancy, in J Am Coll Surg, vol. 185, n. 1, 1997, pp. 33–9, PMID 9208958.
(DE) Länger F, von Wasielewski R, Kreipe HH, [The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas], in Pathologe, vol. 27, n. 4, 2006, pp. 244–50, DOI:10.1007/s00292-006-0836-z, PMID 16758167.
Su C, Tsay S, Wu C, Shyr Y, King K, Lee C, Lui W, Liu T, P'eng F, Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma, in Ann Surg, vol. 223, n. 4, 1996, pp. 384–94, DOI:10.1097/00000658-199604000-00007, PMC 1235134, PMID 8633917.
Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K, Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma, in Int J Radiat Oncol Biol Phys, vol. 46, n. 3, 2000, pp. 581–7, DOI:10.1016/S0360-3016(99)00472-1, PMID 10701737.
Alden M, Mohiuddin M, The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer, in Int J Radiat Oncol Biol Phys, vol. 28, n. 4, 1994, pp. 945–51, DOI:10.1016/0360-3016(94)90115-5, PMID 8138448.
González González D, Gouma D, Rauws E, van Gulik T, Bosma A, Koedooder C, Role of radiotherapy, in particular intraluminal brachytherapy, in the treatment of proximal bile duct carcinoma, in Ann Oncol, 10 Suppl 4, 1999, pp. 215–20, PMID 10436826.
Pitt H, Nakeeb A, Abrams R, Coleman J, Piantadosi S, Yeo C, Lillemore K, Cameron J, Perihilar cholangiocarcinoma. Postoperative radiotherapy does not improve survival, in Ann Surg, vol. 221, n. 6, 1995, pp. 788–97; discussion 797–8, DOI:10.1097/00000658-199506000-00017, PMC 1234714, PMID 7794082.
Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma, in Cancer, vol. 95, n. 8, 2002, pp. 1685–95, DOI:10.1002/cncr.10831, PMID 12365016.
(EN) Junji Furuse, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Hiroya Saito, Toshio Tsuyuguchi and Koichi Hirata, et al., Guidelines for chemotherapy of biliary tract and ampullary carcinomas ^{[collegamento interrotto]}, in Journal of Hepato-Biliary-Pancreatic Surgery, vol. 15, n. 1, pp. 55-62, PMID 18274844.
Glimelius B, Hoffman K, Sjödén P, Jacobsson G, Sellström H, Enander L, Linné T, Svensson C, Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer, in Ann Oncol, vol. 7, n. 6, 1996, pp. 593–600, PMID 8879373.
Choi C, Choi I, Seo J, Kim B, Kim J, Kim C, Um S, Kim J, Kim Y, Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas, in Am J Clin Oncol, vol. 23, n. 4, 2000, pp. 425–8, DOI:10.1097/00000421-200008000-00023, PMID 10955877.
Park J, Oh S, Kim S, Kwon H, Kim J, Jin-Kim H, Kim Y, Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study, in Jpn J Clin Oncol, vol. 35, n. 2, 2005, pp. 68–73, DOI:10.1093/jjco/hyi021, PMID 15709089.
Giuliani F, Gebbia V, Maiello E, Borsellino N, Bajardi E, Colucci G, Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM), in Ann Oncol, 17 Suppl 7, 2006, pp. vii73–vii77, DOI:10.1093/annonc/mdl956, PMID 16760299.
Bhargava P, Jani C, Savarese D, O'Donnell J, Stuart K, Rocha Lima C, Gemcitabine and irinotecan in locally advanced or metastatic biliary cancer: preliminary report, in Oncology (Williston Park), vol. 17, 9 Suppl 8, 2003, pp. 23–6, PMID 14569844.
Knox J, Hedley D, Oza A, Feld R, Siu L, Chen E, Nematollahi M, Pond G, Zhang J, Moore M, Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial, in J Clin Oncol, vol. 23, n. 10, 2005, pp. 2332–8, DOI:10.1200/JCO.2005.51.008, PMID 15800324.
Philip P, Mahoney M, Allmer C, Thomas J, Pitot H, Kim G, Donehower R, Fitch T, Picus J, Erlichman C, Phase II study of erlotinib in patients with advanced biliary cancer, in J Clin Oncol, vol. 24, n. 19, 2006, pp. 3069–74, DOI:10.1200/JCO.2005.05.3579, PMID 16809731.
Ortner M, Caca K, Berr F, Liebetruth J, Mansmann U, Huster D, Voderholzer W, Schachschal G, Mössner J, Lochs H, Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study, in Gastroenterology, vol. 125, n. 5, 2003, pp. 1355–63, DOI:10.1016/j.gastro.2003.07.015, PMID 14598251.
Zoepf T, Jakobs R, Arnold J, Apel D, Riemann J, Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy, in Am J Gastroenterol, vol. 100, n. 11, 2005, pp. 2426–30, DOI:10.1111/j.1572-0241.2005.00318.x, PMID 16279895.
Gut Liver. 2010 Sep;4(Suppl. 1):S62-S66. Epub 2010 Sep 10. Photodynamic Therapy for Cholangiocarcinoma. Talreja JP, Kahaleh M. PMID 21103297
Yamamoto M, Takasaki K, Yoshikawa T, Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma, in Japanese Journal of Clinical Oncology, vol. 29, n. 3, 1999, pp. 147–150, DOI:10.1093/jjco/29.3.147, PMID 10225697.
Farley D, Weaver A, Nagorney D, "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention, in Mayo Clin Proc, vol. 70, n. 5, 1995, pp. 425–9, DOI:10.4065/70.5.425, PMID 7537346.
Grove MK, Hermann RE, Vogt DP, Broughan TA, Role of radiation after operative palliation in cancer of the proximal bile ducts, in Am J Surg, vol. 161, n. 4, 1991, pp. 454–458, DOI:10.1016/0002-9610(91)91111-U, PMID 1709795.
Kaya M, de Groen P, Angulo P, Nagorney D, Gunderson L, Gores G, Haddock M, Lindor K, Treatment of cholangiocarcinoma complicating primary sclerosing cholangitis: the Mayo Clinic experience, in Am J Gastroenterol, vol. 96, n. 4, 2001, pp. 1164–9, DOI:10.1111/j.1572-0241.2001.03696.x, PMID 11316165.
Nakeeb A, Tran K, Black M, Erickson B, Ritch P, Quebbeman E, Wilson S, Demeure M, Rilling W, Dua K, Pitt H, Improved survival in resected biliary malignancies, in Surgery, vol. 132, n. 4, 2002, pp. 555–63; discission 563–4, DOI:10.1067/msy.2002.127555, PMID 12407338.
Khan S, Taylor-Robinson S, Toledano M, Beck A, Elliott P, Thomas H, Changing international trends in mortality rates for liver, biliary and pancreatic tumours, in J Hepatol, vol. 37, n. 6, 2002, pp. 806–13, DOI:10.1016/S0168-8278(02)00297-0, PMID 12445422.
Vauthey J, Blumgart L, Recent advances in the management of cholangiocarcinomas, in Semin Liver Dis, vol. 14, n. 2, 1994, pp. 109–14, DOI:10.1055/s-2007-1007302, PMID 8047893.
Numerosi studi indipendenti hanno documentato una crescita stazionaria nel tasso di incidenza mondiale del colangiocarcinoma; tra gli studi più rilevanti citiamo:
- Patel T, Worldwide trends in mortality from biliary tract malignancies, in BMC Cancer
pubmed.ncbi.nlm.nih.gov
- (EN) Grosso F, Croce A, Libener R, Mariani N, Pastormerlo M, Maconi A, Asbestos Fiber Identification in Liver From Cholangiocarcinoma Patients Living in an Asbestos Polluted Area: A Preliminary Study, su Tumori, 2019 Oct. URL consultato il 3 giugno 2020 (archiviato il 3 giugno 2020).

oadoi.org

Landis S, Murray T, Bolden S, Wingo P, Cancer statistics, 1998, in CA Cancer J Clin, vol. 48, n. 1, 1998, pp. 6–29, DOI:10.3322/canjclin.48.1.6, PMID 9449931.
Tra gli studi epidemiologici che hanno valutato l'incidenza del colangiocarcinoma in individui affetti da colangite sclerosante primitiva sono inclusi:
- Bergquist A, Ekbom A, Olsson R, Kornfeldt D, Lööf L, Danielsson A, Hultcrantz R, Lindgren S, Prytz H, Sandberg-Gertzén H, Almer S, Granath F, Broomé U, Hepatic and extrahepatic malignancies in primary sclerosing cholangitis, in J Hepatol
- Sahani D, Prasad S, Tannabe K, Hahn P, Mueller P, Saini S, Thorotrast-induced cholangiocarcinoma: case report, in Abdom Imaging, vol. 28, n. 1, 2003, pp. 72–4, DOI:10.1007/s00261-001-0148-y, PMID 12483389.
- Zhu A, Lauwers G, Tanabe K, Cholangiocarcinoma in association with Thorotrast exposure, in J Hepatobiliary Pancreat Surg, vol. 11, n. 6, 2004, pp. 430–3, DOI:10.1007/s00534-004-0924-5, PMID 15619021.
- Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Arase Y, Murashima N, Chayama K, Kumada H, <2471::AID-CNCR7>3.0.CO;2-T Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis, in Cancer, vol. 88, n. 11, 2000, pp. 2471–7, DOI:10.1002/1097-0142(20000601)88:11<2471::AID-CNCR7>3.0.CO;2-T, PMID 10861422.
- Dayton M, Longmire W, Tompkins R, Caroli's Disease: a premalignant condition?, in Am J Surg, vol. 145, n. 1, 1983, pp. 41–8, DOI:10.1016/0002-9610(83)90164-2, PMID 6295196.
- Mecklin J, Järvinen H, Virolainen M, The association between cholangiocarcinoma and hereditary nonpolyposis colorectal carcinoma, in Cancer, vol. 69, n. 5, 1992, pp. 1112–4, DOI:10.1002/cncr.2820690508, PMID 1310886.
- Lee S, Kim M, Lee S, Jang S, Song M, Kim K, Kim H, Seo D, Song D, Yu E, Lee S, Min Y, Clinicopathologic review of 58 patients with biliary papillomatosis, in Cancer, vol. 100, n. 4, 2004, pp. 783–93, DOI:10.1002/cncr.20031, PMID 14770435.
- Donato F, Gelatti U, Tagger A, Favret M, Ribero M, Callea F, Martelli C, Savio A, Trevisi P, Nardi G, Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy, in Cancer Causes Control, vol. 12, n. 10, 2001, pp. 959–64, DOI:10.1023/A:1013747228572, PMID 11808716.
- Roskams T, Liver stem cells and their implication in hepatocellular and cholangiocarcinoma, in Oncogene, vol. 25, n. 27, 2006, pp. 3818–22, DOI:10.1038/sj.onc.1209558, PMID 16799623.
- Sirica A, Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy, in Hepatology, vol. 41, n. 1, 2005, pp. 5–15, DOI:10.1002/hep.20537, PMID 15690474.
- de Groen P, Gores G, LaRusso N, Gunderson L, Nagorney D, Biliary tract cancers, in N Engl J Med, vol. 341, n. 18, 1999, pp. 1368–78, DOI:10.1056/NEJM199910283411807, PMID 10536130.
- Henson D, Albores-Saavedra J, Corle D, <1498::AID-CNCR2820700609>3.0.CO;2-C Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease, grade, and survival rates, in Cancer, vol. 70, n. 6, 1992, pp. 1498–501, DOI:10.1002/1097-0142(19920915)70:6<1498::AID-CNCR2820700609>3.0.CO;2-C, PMID 1516001.
- Saini S, Imaging of the hepatobiliary tract, in N Engl J Med, vol. 336, n. 26, 1997, pp. 1889–94, DOI:10.1056/NEJM199706263362607, PMID 9197218.
- Valls C, Gumà A, Puig I, Sanchez A, Andía E, Serrano T, Figueras J, Intrahepatic peripheral cholangiocarcinoma: CT evaluation, in Abdom Imaging, vol. 25, n. 5, 2000, pp. 490–6, DOI:10.1007/s002610000079, PMID 10931983.
- Zhang Y, Uchida M, Abe T, Nishimura H, Hayabuchi N, Nakashima Y, Intrahepatic peripheral cholangiocarcinoma: comparison of dynamic CT and dynamic MRI, in J Comput Assist Tomogr, vol. 23, n. 5, 1999, pp. 670–7, DOI:10.1097/00004728-199909000-00004, PMID 10524843.
- Sugiyama M, Hagi H, Atomi Y, Saito M, Diagnosis of portal venous invasion by pancreatobiliary carcinoma: value of endoscopic ultrasonography, in Abdom Imaging, vol. 22, n. 4, 1997, pp. 434–8, DOI:10.1007/s002619900227, PMID 9157867.
- Szklaruk J, Tamm E, Charnsangavej C, Preoperative imaging of biliary tract cancers, in Surg Oncol Clin N Am, vol. 11, n. 4, 2002, pp. 865–76, DOI:10.1016/S1055-3207(02)00032-7, PMID 12607576.
- (DE) Länger F, von Wasielewski R, Kreipe HH, [The importance of immunohistochemistry for the diagnosis of cholangiocarcinomas], in Pathologe, vol. 27, n. 4, 2006, pp. 244–50, DOI:10.1007/s00292-006-0836-z, PMID 16758167.
- Todoroki T, Ohara K, Kawamoto T, Koike N, Yoshida S, Kashiwagi H, Otsuka M, Fukao K, Benefits of adjuvant radiotherapy after radical resection of locally advanced main hepatic duct carcinoma, in Int J Radiat Oncol Biol Phys, vol. 46, n. 3, 2000, pp. 581–7, DOI:10.1016/S0360-3016(99)00472-1, PMID 10701737.
- Alden M, Mohiuddin M, The impact of radiation dose in combined external beam and intraluminal Ir-192 brachytherapy for bile duct cancer, in Int J Radiat Oncol Biol Phys, vol. 28, n. 4, 1994, pp. 945–51, DOI:10.1016/0360-3016(94)90115-5, PMID 8138448.
- Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, Nagakawa T, Nakayama T, Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma, in Cancer, vol. 95, n. 8, 2002, pp. 1685–95, DOI:10.1002/cncr.10831, PMID 12365016.
- Choi C, Choi I, Seo J, Kim B, Kim J, Kim C, Um S, Kim J, Kim Y, Effects of 5-fluorouracil and leucovorin in the treatment of pancreatic-biliary tract adenocarcinomas, in Am J Clin Oncol, vol. 23, n. 4, 2000, pp. 425–8, DOI:10.1097/00000421-200008000-00023, PMID 10955877.
- Park J, Oh S, Kim S, Kwon H, Kim J, Jin-Kim H, Kim Y, Single-agent gemcitabine in the treatment of advanced biliary tract cancers: a phase II study, in Jpn J Clin Oncol, vol. 35, n. 2, 2005, pp. 68–73, DOI:10.1093/jjco/hyi021, PMID 15709089.
- Giuliani F, Gebbia V, Maiello E, Borsellino N, Bajardi E, Colucci G, Gemcitabine and cisplatin for inoperable and/or metastatic biliary tree carcinomas: a multicenter phase II study of the Gruppo Oncologico dell'Italia Meridionale (GOIM), in Ann Oncol, 17 Suppl 7, 2006, pp. vii73–vii77, DOI:10.1093/annonc/mdl956, PMID 16760299.
- Knox J, Hedley D, Oza A, Feld R, Siu L, Chen E, Nematollahi M, Pond G, Zhang J, Moore M, Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial, in J Clin Oncol, vol. 23, n. 10, 2005, pp. 2332–8, DOI:10.1200/JCO.2005.51.008, PMID 15800324.
- Philip P, Mahoney M, Allmer C, Thomas J, Pitot H, Kim G, Donehower R, Fitch T, Picus J, Erlichman C, Phase II study of erlotinib in patients with advanced biliary cancer, in J Clin Oncol, vol. 24, n. 19, 2006, pp. 3069–74, DOI:10.1200/JCO.2005.05.3579, PMID 16809731.
- Yamamoto M, Takasaki K, Yoshikawa T, Lymph Node Metastasis in Intrahepatic Cholangiocarcinoma, in Japanese Journal of Clinical Oncology, vol. 29, n. 3, 1999, pp. 147–150, DOI:10.1093/jjco/29.3.147, PMID 10225697.
- Khan S, Taylor-Robinson S, Toledano M, Beck A, Elliott P, Thomas H, Changing international trends in mortality rates for liver, biliary and pancreatic tumours, in J Hepatol, vol. 37, n. 6, 2002, pp. 806–13, DOI:10.1016/S0168-8278(02)00297-0, PMID 12445422.

springerlink.com

(EN) Junji Furuse, Tadahiro Takada, Masaru Miyazaki, Shuichi Miyakawa, Kazuhiro Tsukada, Masato Nagino, Satoshi Kondo, Hiroya Saito, Toshio Tsuyuguchi and Koichi Hirata, et al., Guidelines for chemotherapy of biliary tract and ampullary carcinomas ^{[collegamento interrotto]}, in Journal of Hepato-Biliary-Pancreatic Surgery, vol. 15, n. 1, pp. 55-62, PMID 18274844.

startoncology.net

Colangiocarcinoma ^{[collegamento interrotto]}, su startoncology.net, Startoncology. URL consultato il 2 gennaio 2012.

usc.edu

surgery.usc.edu

Bile duct cancer: cause and treatment, su surgery.usc.edu. URL consultato il 15 ottobre 2011 (archiviato il 23 aprile 2018).

web.archive.org

Bile duct cancer: cause and treatment, su surgery.usc.edu. URL consultato il 15 ottobre 2011 (archiviato il 23 aprile 2018).
(EN) Grosso F, Croce A, Libener R, Mariani N, Pastormerlo M, Maconi A, Asbestos Fiber Identification in Liver From Cholangiocarcinoma Patients Living in an Asbestos Polluted Area: A Preliminary Study, su Tumori, 2019 Oct. URL consultato il 3 giugno 2020 (archiviato il 3 giugno 2020).
(EN) Stadiazione: Domande & Risposte" a cura dell'Istituto Nazionale dei Tumori Americano, su cancer.gov. URL consultato il 2 gennaio 2012 (archiviato il 19 marzo 2015).
(EN) National Comprehensive Cancer Network (NCCN) guidelines on evaluation and treatment of hepatobiliary malignancies (PDF), su nccn.org. URL consultato il 13 marzo 2007 (archiviato il 26 marzo 2009).
Colangiocarcinoma, su fondazionefegato.it, Fondazione Italiana per la Ricerca in Epatologia. URL consultato il 2 gennaio 2011 (archiviato il 17 settembre 2011).
Copia archiviata (PDF), su seer.cancer.gov. URL consultato il 15 ottobre 2011 (archiviato il 15 ottobre 2011).
Cancer Statistics Home Page - National Cancer Institute, su cancer.gov. URL consultato il 15 ottobre 2011 (archiviato il 29 aprile 2015).

Colangiocarcinoma (Italian Wikipedia)

archive.org

cancer.gov

cancer.gov

seer.cancer.gov

doi.org

dx.doi.org

fondazionefegato.it

nccn.org

nih.gov

ncbi.nlm.nih.gov

pubmed.ncbi.nlm.nih.gov

oadoi.org

springerlink.com

startoncology.net

usc.edu

surgery.usc.edu

web.archive.org